Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. 2008

Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
Department of Pharmacology, National Research Institute for Child Health and Development, Tokyo, Japan.

The neuropeptide hormone arginine-vasopressin (AVP) is well known to exert its antidiuretic effect via the vasopressin V2 receptor (V2R), whereas the role of the vasopressin V1a receptor (V1aR) in the kidney remains to be clarified. Previously, we reported decreased plasma volume and blood pressure in V1a receptor-deficient (V1aR-/-) mice (Koshimizu T, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T. Proc Natl Acad Sci USA 103: 7807-7812, 2006). In this study, we investigated the role of V1aR in urine concentration, renal function, and the renin-angiotensin system (RAS) using V1aR-/- mice. Urine volume of V1aR-/- mice was greater than that of wild-type mice, particularly when water was loaded, while the glomerular filtration rate (GFR), urinary NaCl excretion, AVP-dependent cAMP generation, V2R, and aquaporin 2 (AQP2) expression in the kidney were lower, indicating that the diminished GFR and V2R-AQP2 system led to impaired urinary concentration in V1aR-/- mice. Since the GFR and V2R-AQP2 system are regulated by RAS, we analyzed renin and angiotensin II in V1aR-/- mice and found that the plasma renin and angiotensin II were decreased. The expression of renin in granule cells was decreased in V1aR-/- mice, which led to a decreased level of plasma renin. In addition, the expression of renin stimulators such as neuronal nitric oxide synthase and cyclooxygenase-2 in macula densa (MD) cells, where V1aR was specifically expressed, was decreased in V1aR-/- mice. These data indicate that AVP regulates body fluid homeostasis and GFR via the V1aR in MD cells by activating RAS and subsequently the V2R-AQP2 system.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007686 Kidney Tubules, Distal The portion of renal tubule that begins from the enlarged segment of the ascending limb of the LOOP OF HENLE. It reenters the KIDNEY CORTEX and forms the convoluted segments of the distal tubule. Distal Kidney Tubule,Distal Renal Tubule,Distal Kidney Tubules,Distal Renal Tubules,Kidney Tubule, Distal,Renal Tubule, Distal,Renal Tubules, Distal,Tubule, Distal Kidney,Tubule, Distal Renal,Tubules, Distal Kidney,Tubules, Distal Renal
D008297 Male Males
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014667 Vasopressins Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure. Antidiuretic Hormone,Antidiuretic Hormones,beta-Hypophamine,Pitressin,Vasopressin,Vasopressin (USP),Hormone, Antidiuretic,beta Hypophamine
D014882 Water-Electrolyte Balance The balance of fluid in the BODY FLUID COMPARTMENTS; total BODY WATER; BLOOD VOLUME; EXTRACELLULAR SPACE; INTRACELLULAR SPACE, maintained by processes in the body that regulate the intake and excretion of WATER and ELECTROLYTES, particularly SODIUM and POTASSIUM. Fluid Balance,Electrolyte Balance,Balance, Electrolyte,Balance, Fluid,Balance, Water-Electrolyte,Water Electrolyte Balance

Related Publications

Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
September 1999, Hypertension (Dallas, Tex. : 1979),
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
September 2011, American journal of physiology. Renal physiology,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
January 1999, Journal of the American Society of Nephrology : JASN,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
March 2012, Hypertension (Dallas, Tex. : 1979),
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
November 2001, Kidney international,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
April 1982, The Journal of surgical research,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
August 1993, The American journal of physiology,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
February 2020, Current hypertension reports,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
January 1991, Renal physiology and biochemistry,
Toshinori Aoyagi, and Yuichiro Izumi, and Masami Hiroyama, and Takanobu Matsuzaki, and Yukiko Yasuoka, and Atsushi Sanbe, and Hiroki Miyazaki, and Yoko Fujiwara, and Yushi Nakayama, and Yukimasa Kohda, and Junji Yamauchi, and Takeaki Inoue, and Katsumasa Kawahara, and Hideyuki Saito, and Kimio Tomita, and Hiroshi Nonoguchi, and Akito Tanoue
June 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!